搜索临床试验以:mRNA-CR-04疫苗10μg
总计216个结果
-
Hospital Moinhos de VentoPfizer; Universidade Federal do Paraná; Inova Medical完全的
-
National Institute of Allergy and Infectious Diseases...National Heart, Lung, and Blood Institute (NHLBI); University of Copenhagen; US Department of... 和其他合作者完全的
-
Bayside HealthMonash University招聘中淋巴瘤,非霍奇金 | 多发性骨髓瘤 | 艾滋病病毒 | 慢性淋巴细胞白血病 | 器官移植 | 2019冠状病毒病疫苗澳大利亚
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR); Samuel Lunenfeld Research Institute, Mount Sinai... 和其他合作者主动,不招人
-
Jiangsu Province Centers for Disease Control and...Changchun Institute of Biological Products Co., Ltd.完全的
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological Pharmaceutical Co...主动,不招人
-
Italian Group for the study of Inflammatory Bowel...未知
-
University of MichiganThe Wallace Foundation招聘中
-
University of ManitobaPublic Health Agency of Canada (PHAC); Cadham Provincial Lab尚未招聘新冠肺炎
-
Universidad del DesarrolloPontificia Universidad Catolica de Chile; University of Chile; Ministry of Health, Chile主动,不招人
-
Catholic Kwandong UniversityKorea University Guro Hospital完全的
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological Pharmaceutical Co...主动,不招人
-
Mayo Clinic终止
-
AIM Vaccine Co., Ltd.First Affiliated Hospital Bengbu Medical College; Ningbo Rongan Biological Pharmaceutical Co...尚未招聘
-
AIM Vaccine Co., Ltd.Zhejiang Provincial Center for Disease Control and Prevention尚未招聘
-
ModernaTX, Inc.完全的
-
CNBG-Virogin Biotech (Shanghai) Ltd.招聘中
-
Johns Hopkins UniversityIntegrated Research Center for Fetal Medicine招聘中
-
Merck Sharp & Dohme LLC完全的乳头瘤病毒感染 | 冠状病毒病 (COVID-19)美国
-
Murdoch Childrens Research Institute完全的
-
BayerCureVac撤销2019 冠状病毒病 (COVID-19) | SARS-CoV-2 感染
-
Chulalongkorn UniversityBioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine, Chulalongkorn... 和其他合作者招聘中25 ug ChulaCov19-BNA159 mRNA 疫苗的安全性 | 25 ug ChulaCov19-BNA159 mRNA 疫苗的耐受性 | 25 ug ChulaCov19-BNA159 mRNA 疫苗的免疫反应 | 50 ug ChulaCov19-BNA159 mRNA 疫苗的安全性 | 50 ug ChulaCov19-BNA159 mRNA 疫苗的耐受性 | 50 ug ChulaCov19-BNA159 mRNA 疫苗的免疫反应 | 评估哪种剂量适合使用泰国
-
Changhai HospitalStemirna Therapeutics未知
-
Stemirna TherapeuticsThe First Affiliated Hospital of Zhengzhou University招聘中
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...完全的新冠肺炎 | 疫苗不良反应 | 疫苗反应 | 肝移植;并发症 | 肺移植;并发症 | 疫苗反应受损 | 疫苗接种意大利
-
National Institute of Allergy and Infectious Diseases...招聘中
-
Sinocelltech Ltd.撤销新冠肺炎 | SARS-CoV-2 感染
-
Shanghai Institute Of Biological ProductsHenan Center for Disease Control and Prevention未知
-
McMaster UniversityUniversity of Manitoba; University of Alberta; University of Saskatchewan撤销
-
Hospital Moinhos de VentoPfizer; Universidade Federal do Paraná; Inova Medical完全的
-
Sanofi Pasteur, a Sanofi Company完全的
-
Korea University Guro HospitalKorea University Anam Hospital; Ajou University School of Medicine; Korean Center for Disease... 和其他合作者招聘中
-
Ente Ospedaliero Ospedali GallieraUniversity of Genoa招聘中